You have 9 free searches left this month | for more free features.

dostarlimab

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HRD, Cholangiocarcinoma, Metastatic Cancer Trial (Niraparib, Dostarlimab)

Withdrawn
  • HRD
  • +2 more
  • (no location specified)
Jun 23, 2022

Gestational Trophoblastic Neoplasia Trial in Miami (Dostarlimab)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Dostarlimab
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Jul 15, 2022

Colon Cancer, DMMR Colorectal Cancer Trial (Dostarlimab)

Not yet recruiting
  • Colon Cancer
  • DMMR Colorectal Cancer
  • Dostarlimab
  • (no location specified)
Feb 4, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Oct 18, 2021

Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)

Recruiting
  • Head and Neck Cancer
  • Cincinnati, Ohio
  • +1 more
Sep 15, 2021

Tumors Trial in France, Spain, United Kingdom (Niraparib, Dostarlimab)

Recruiting
  • Neoplasms
  • Lille, France
  • +11 more
Jun 13, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +2 more
Apr 13, 2022

Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

Recruiting
  • Lung Small Cell Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

Ovarian Cancer Trial in Italy (Niraparib, Dostarlimab, Pegylated liposomal doxorubicin)

Recruiting
  • Ovarian Cancer
  • Brescia, Italy
  • +7 more
Aug 24, 2021

Urothelial Bladder Cancer, Gastric Adenocarcinoma, Gastro-oesophageal Adenocarcinoma Trial (Dostarlimab, Niraparib)

Not yet recruiting
  • Urothelial Bladder Cancer
  • +6 more
  • (no location specified)
Feb 26, 2021

Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)

Recruiting
  • Endometrial Cancer
  • Intensity modulated radiation therapy (IMRT)
  • Dostarlimab
  • Basking Ridge, New Jersey
  • +6 more
Jul 5, 2022

Endometrial Cancer Trial in France (Carboplatin-Paclitaxel, Dostarlimab)

Recruiting
  • Endometrial Cancer
  • Angers, France
  • +40 more
Aug 9, 2022

Lung Cancer, Non-Small Cell Trial in Caen Cedex 9, Montpellier Cedex (Pembrolizumab, Dostarlimab, GSK4428859A)

Not yet recruiting
  • Lung Cancer, Non-Small Cell
  • Caen Cedex 9, France
  • +1 more
Sep 30, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Niraparib, Dostarlimab, Bevacizumab)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 2, 2022

Lung Cancer, Non-Small Cell Trial in Worldwide (Cobolimab, Dostarlimab, Docetaxel)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Cobolimab
  • +2 more
  • Fountain Valley, California
  • +106 more
Apr 12, 2022

Lung Cancer, Non-Small Cell Trial in Worldwide (Dostarlimab, Pembrolizumab, Chemotherapy)

Active, not recruiting
  • Lung Cancer, Non-Small Cell
  • Dostarlimab
  • +2 more
  • Lone Tree, Colorado
  • +65 more
Jun 26, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +51 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 15, 2022